Read more about the different options for managing hyperthyroidism in cats.
Pharmacokinetics of once daily prolonged-release carbimazole oral tablets in cats with hyperthyroidism.
More information about the treatment and management of hyperthyroidism.
Hyperthyroidism was not recognized as a clinical problem in cats until 1979. It is now considered the most common endocrinopathy in cats.
This website is intended for veterinarians to provide information about hyperthyroidism in cats. It also serves as a reference for Vidalta®(known as Vidalta® Vet in Belgium and Norway), Merck Animal Health's prolonged-release carbimazole for the management of hyperthyroidism in cats.
Some parts of this website are for veterinarians only, veterinarians can register by following the registration link.
Hyperthyroidism-cat.com is a website for owners of cats diagnosed with hyperthyroidism. It contains information on the disease, treatment and management options and a frequently asked questions section.
Merck Animal Health is a global leader in the discovery, development, manufacture and sale of veterinary medicines. The result of the combination of two major companies in the animal health sector, our company offers customers one of the industry's broadest, most innovative portfolios, spanning products to support performance and to prevent, treat and control disease in all major farm and companion animal species.
Optional image caption
A pull quote. Use this box to repeat an important message from the main content of this page.
Optional Name